Michael A. Mussallem - 02 May 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: Director
Issuer ticker: EW
Reported as of: 02 May 2024
Net transaction value: -$1,409,353
SEC form: 4
Accepted by SEC: 02 May 2024, 18:05:06 UTC
Prior SEC filing: 04 Apr 2024
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Michael A. Mussallem filed Form 4 for Edwards Lifesciences Corp (EW) on 02 May 2024.

Key facts

This page summarizes Michael A. Mussallem's Form 4 filing for Edwards Lifesciences Corp (EW).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 May 2024, 18:05.

Change

Previous filing in this sequence was filed on 04 Apr 2024.
Current net transaction value: -$1,409,353.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Options Exercise

Transaction value: $1,078,612
Shares: +29,350
Change %: +654%
Price: $36.75
Shares after: 33,836
Date: 02 May 2024
Ownership: Direct
Footnotes: F1

EW transaction

Common Stock

Sale

Transaction value: $1,037,839
Shares: -12,207
Change %: -36%
Price: $85.02
Shares after: 21,629
Date: 02 May 2024
Ownership: Direct
Footnotes: F1, F2

EW transaction

Common Stock

Sale

Transaction value: $1,450,126
Shares: -17,143
Change %: -79%
Price: $84.59
Shares after: 4,486
Date: 02 May 2024
Ownership: Direct
Footnotes: F1, F3

EW holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,038,377
Date: 02 May 2024
Ownership: By Living Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EW transaction Derivative

Employee Stock Option (Right to Acquire)

Options Exercise

Transaction value: $0
Shares: -29,350
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,350
Exercise price: $36.75

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $84.865 to $85.420. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $83.860 to $84.860. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.